← stocks-llm New chat

Medline Inc. (MDLN) — insider trading

Health Care · NASDAQ

Medline Inc. (MDLN) has 20 reported SEC Form 4 insider transactions in our data, including 1 open-market purchase and 2 open-market sales among the most recent 20 (latest 2026-06-16).

Recent Form 4 transactions

DateInsiderRoleTypeSharesPriceValueFiling
2026-06-16 Golwas Douglas P Officer (Chief Commercial Officer), 10% owner Option exercise / conversion (derivative) 100,000 $0.00 $0 Form 4
2026-06-16 Golwas Douglas P Officer (Chief Commercial Officer), 10% owner Disposition to the issuer 100,000 Form 4
2026-06-16 Golwas Douglas P Officer (Chief Commercial Officer), 10% owner Open-market sale 38,034 $37.05 $1.41M Form 4
2026-06-16 Golwas Douglas P Officer (Chief Commercial Officer), 10% owner Open-market sale 61,966 $36.60 $2.27M Form 4
2026-06-16 Golwas Douglas P Officer (Chief Commercial Officer), 10% owner Option exercise / conversion 100,000 Form 4
2026-06-15 Boyle James M Director, Officer (Chief Executive Officer) Shares withheld for taxes / exercise cost 2,370 $36.61 $86.8K Form 4
2026-06-15 Golwas Douglas P Officer (Chief Commercial Officer), 10% owner Shares withheld for taxes / exercise cost 1,889 $36.61 $69.2K Form 4
2026-06-15 Drazin Michael B Officer (Chief Financial Officer) Shares withheld for taxes / exercise cost 1,889 $36.61 $69.2K Form 4
2026-06-15 Laabs Amanda H. Officer (Chief Product Officer) Shares withheld for taxes / exercise cost 1,889 $36.61 $69.2K Form 4
2026-06-15 Liberman Alexander M. Officer (Chief Legal Officer) Shares withheld for taxes / exercise cost 872 $36.61 $31.9K Form 4
2026-06-15 Miller Stephen L Officer (Chief Operating Officer) Shares withheld for taxes / exercise cost 1,889 $36.61 $69.2K Form 4
2026-06-15 Shryock Christopher P Officer (Chief Human Resources Officer) Shares withheld for taxes / exercise cost 872 $36.61 $31.9K Form 4
2026-06-15 Abrams William J Officer (See Remarks) Shares withheld for taxes / exercise cost 1,308 $36.61 $47.9K Form 4
2026-06-11 Bluedorn Todd M Director Grant / award / vesting 5,387 $0.00 $0 Form 4
2026-06-11 Sweet Thomas W Director Grant / award / vesting 5,387 $0.00 $0 Form 4
2026-06-11 GALANTI RICHARD A Director Grant / award / vesting 5,387 $0.00 $0 Form 4
2026-06-05 CORCORAN JESSI L Officer (Principal Accounting Officer) Open-market purchase 5,000 $34.15 $170.8K Form 4
2025-12-16 Bluedorn Todd M Director Grant / award / vesting 10,345 $0.00 $0 Form 4
2025-12-16 Sweet Thomas W Director Grant / award / vesting 12,413 Form 4
2025-12-16 GALANTI RICHARD A Director Grant / award / vesting 11,005 Form 4

Ask the chat about MDLN's insider activity →

Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.

Source: SEC EDGAR Form 3/4/5. See the full company profile: Medline Inc. (MDLN).

Last updated 2026-06-16 (most recent filing date).

Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.